Arginase Deficiency Latest Advances
Find the Latest Research About Arginase Deficiency
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 313 publications
Arginase 2 deficiency mitigates sepsis-associated acute kidney injury by alleviating lipid accumulation.
Journal: Clinical and translational medicine
Published: June 04, 2026
Pegzilarginase in Arginase 1 Deficiency: Clinical and Biochemical Effects of Treatment Initiation, Discontinuation and Re-Initiation.
Journal: Children (Basel, Switzerland)
Published: April 02, 2026
Extracellular Vesicles Delivered a Functional ARG1 Enzyme and Restored Its Activity in a Mouse Model of ARG1-D Resulting in Improved Lifespan.
Journal: International journal of molecular sciences
Published: April 01, 2026
Efficacy and safety of pegzilarginase in patients below 2 years of age with arginase 1 deficiency: a phase 3, open-label, multi-centre study.
Journal: EClinicalMedicine
Published: March 27, 2026
Relationship between elevated arginine and pathophysiology of progressive disease in arginase 1 deficiency.
Journal: Molecular genetics and metabolism
Published: March 16, 2026
Prevalence, Disease Onset and Clinical Outcome in Arginase 1 Deficiency: Cross-Border Surveillance in Germany, Austria, and Switzerland.
Journal: Journal of inherited metabolic disease
Published: March 11, 2026
A hybrid piggyBac AAV-transposon and LNP-transposase for treating arginase deficiency: A 100-fold dose reduction compared to AAV alone.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 07, 2025
Cluster of Severe Arginase 1 Deficiency in the Comoros: Clinical, Neuroimaging, and Molecular Features in 17 Patients From Mayotte Compared With 10 From Paris.
Journal: Journal of inherited metabolic disease
Published: October 07, 2025
Cluster of Severe Arginase 1 Deficiency in the Comoros: Clinical, Neuroimaging, and Molecular Features in 17 Patients From Mayotte Compared With 10 From Paris.
Journal: Journal of inherited metabolic disease
Published: October 07, 2025
Correction to "Long-Term Efficacy and Tolerability of Pegzilarginase in Arginase 1 Deficiency: Results of Two International Multicentre Open-Label Extension Studies".
Journal: Journal of inherited metabolic disease
Published: September 10, 2025
Clinical Characteristics of Arginase 1 Deficiency: Natural History Insights From International Clinical Trials.
Journal: Journal of inherited metabolic disease
Published: September 03, 2025
Last Updated: 11/08/2026